Henoch–Schönlein Purpura with Gastrointestinal Involvement in an Adult Patient: A Case Report

Authors

  • Seno Lamsir Dermatology, Venereology And Aesthetics Division Dr. Moewardi General Hospital, Ministry of Health Republic Indonesia
  • Endra Yustin Ellistasari Dermatology, Venereology And Aesthetics Division Dr. Moewardi General Hospital, Ministry of Health Republic Indonesia
  • Ervina Rosmarwati Dermatology, Venereology And Aesthetics Division Dr. Moewardi General Hospital, Ministry of Health Republic Indonesia
  • Prasetyadi Mawardi Dermatology, Venereology And Aesthetics Division Dr. Moewardi General Hospital, Ministry of Health Republic Indonesia

DOI:

https://doi.org/10.11594/ibehs.vol14iss2pp111-115

Keywords:

Corticosteroids, Gastrointestinal bleeding, Henoch–Schönlein Purpura, IgA vasculitis, Palpable Purpura

Abstract

Introduction

Henoch–Schönlein purpura (HSP), also known as IgA vasculitis, is a systemic small-vessel vasculitis characterized by IgA immune complex deposition. Although predominantly a childhood disease with a generally favorable prognosis, adult cases often exhibit more severe systemic involvement, particularly affecting the gastrointestinal tract and kidneys.

Case

A 22-year-old female presented with palpable purpura on the extremities, arthralgia, and melena. Physical examination revealed confluent purpuric lesions over the arms and legs. Endoscopy revealed esophagitis and antral gastritis. Skin biopsy demonstrated flattening of rete ridges and perivascular infiltrates, consistent with leukocytoclastic vasculitis. The patient was treated with intravenous methylprednisolone and supportive therapy, resulting in significant improvement of skin lesions, joint pain, and resolution of gastrointestinal bleeding.

Discussion

Adult HSP is less common but typically has a more severe course compared to pediatric cases. Gastrointestinal involvement, as seen in this case, may present as bleeding, ischemia, or ulceration, and can be life-threatening. Corticosteroids are effective in controlling inflammation and alleviating symptoms but do not prevent renal complications. Continuous renal monitoring is crucial, as kidney involvement remains the primary determinant of long-term prognosis.

Conclusion

This case highlights the clinical relevance of HSP in adults, where gastrointestinal manifestations may predominate and require aggressive management. Long-term follow-up, especially for renal involvement, is essential to improve outcomes.

References

Cao T, Yang H, Huang J and Hu Y (2023). Risk Factors Associated with Recurrence of Henoch – Schonlein Purpura : A Retrospective Study, (June), pp.: 2–7. doi: 10.3389/fped.2023.1164099.

Castañeda S, Quiroga-colina P, Floranes P and Uriarte-ecenarro M (2024). IgA Vasculitis ( Henoch – Schönlein Purpura ): An Update on Treatment, pp.: 1–21.

Chen J and Mao J (2015). Henoch-Schönlein Purpura Nephritis in Children: Incidence, Pathogenesis and Management, 11(1). doi: 10.1007/s12519-014-0534-5.

Davin J (2006). Henoch – Scho ¨ Nlein Purpura, 5(05). doi: 10.1016/S1571-5078(05)05018-X.

Davin J and Coppo R (2014). Henoch – Schönlein Purpura Nephritis. Nature Publishing Group, 10(10), pp.: 563–573. doi: 10.1038/nrneph.2014.126.

Heineke MH, Ballering A V, Jamin A, Ben S, Monteiro RC and Egmond M Van (2017). Autoimmunity Reviews New Insights in the Pathogenesis of Immunoglobulin A Vasculitis ( Henoch-Schönlein Purpura ). Autoimmunity Reviews, 16(12), pp.: 1246–1253. doi: 10.1016/j.autrev.2017.10.009.

Hetland LE (2017). Henoch-Schönlein Purpura: A Literature Review 1, pp.: 1160–1166. doi: 10.2340/00015555-2733.

Kawasaki Y (2022). Treatment Strategy with Multidrug Therapy and Tonsillectomy Pulse Therapy for Childhood ‑ Onset Severe IgA Nephropathy. Clinical and Experimental Nephrology, 26(6), pp.: 501–511. doi: 10.1007/s10157-022-02187-z.

Maritati F, Fenoglio R, Pillebout E, Emmi G, Urban ML, Rocco R, Sc MNB, Incerti M, et al. (2020). Rituximab for Refractory IgAV, pp.: 0–2. doi: 10.1111/ijlh.12426.

Perre E Van De, Jones RB and Jayne DRW (2021). IgA Vasculitis ( Henoch – Scho ¨ Nlein Purpura ): Refractory and Relapsing Disease Course in the Adult Population, 14(8), pp.: 1953–1960. doi: 10.1093/ckj/sfaa251.

Pillebout L, Thervet E, Hill G, Alberti C and Inserm U (2002). Henoch-Scho ¨ Nlein Purpura in Adults : Outcome and Prognostic Factors, pp.: 1271–1278. doi: 10.1097/01.ASN.0000013883.99976.22.

Reamy B V, Servey JT and Williams PM (2020). Henoch-Schönlein Purpura ( IgA Vasculitis ): Rapid Evidence Review, pp.: 229–233.

Sestan M and Jelusic M (2023). Diagnostic and Management Strategies of IgA Vasculitis Nephritis / Henoch-Schönlein Perspectives Diagnostic and Management Strategies of IgA Vasculitis Nephritis / Henoch-Schönlein Purpura Nephritis in Pediatric Patients : Current Perspectives, 9927. doi: 10.2147/PHMT.S379862.

Xu L, Li Y and Wu X (2022). IgA Vasculitis Update : Epidemiology , Pathogenesis , and Biomarkers, (October), pp.: 1–17. doi: 10.3389/fimmu.2022.921864.

Downloads

Published

29-04-2026

How to Cite

Lamsir, S., Yustin Ellistasari, E., Rosmarwati, E., & Mawardi, P. (2026). Henoch–Schönlein Purpura with Gastrointestinal Involvement in an Adult Patient: A Case Report. Indonesian Basic and Experimental Health Sciences, 14(2), 111–115. https://doi.org/10.11594/ibehs.vol14iss2pp111-115

Issue

Section

Articles